Using Roche Holding's Lucentis drug helped improve the vision and curb blood vessel abnormalities in patients with diabetes-related macular edema, experts reported at the annual meeting of the American Diabetes Association. Lucentis-treated patients were more likely to have 20/40 vision compared with those who took a placebo, experts said.

Full Story:

Related Summaries